Skip to content

Trevi Therapeutics, Inc. TRVI Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$22M-40.5%
LQD
Liquidia CorporationLQDA
$4.36M+5.5%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s operating lease ROU assets?
Trevi Therapeutics, Inc. (TRVI) reported operating lease ROU assets of $610K in Q1 2026.
How has Trevi Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Trevi Therapeutics, Inc.'s operating lease ROU assets decreased by 29.5% year-over-year, from $865K to $610K.
What is the long-term trend for Trevi Therapeutics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s operating lease ROU assets has grown at a 24.4% compound annual growth rate (CAGR), from $227K to $677K.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.